Cargando…
Current Status of Pancreas and Islet Cell Transplantation
Pancreas transplantation has emerged as an effective treatment for patients with diabetes mellitus, especially those with established end-stage renal disease. Surgical and immunosuppressive advances have significantly improved allograft survival. The procedure reduces mortality compared with diabeti...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Organ Transplantation Institute
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089283/ https://www.ncbi.nlm.nih.gov/pubmed/25013624 |
_version_ | 1782325102032977920 |
---|---|
author | Saidi, R. F. |
author_facet | Saidi, R. F. |
author_sort | Saidi, R. F. |
collection | PubMed |
description | Pancreas transplantation has emerged as an effective treatment for patients with diabetes mellitus, especially those with established end-stage renal disease. Surgical and immunosuppressive advances have significantly improved allograft survival. The procedure reduces mortality compared with diabetic kidney transplant recipients and wait listed patients. Improvements in diabetic nephropathy and retinopathy have also been demonstrated. Pancreas transplantation can improve cardiovascular risk profiles, improve cardiac function and decrease cardiovascular events. Lastly, improvements in diabetic neuropathy and quality of life can result from pancreas transplantation. Pancreas transplantation remains the most effective method to establish durable euglycemia for patients with diabetes mellitus. |
format | Online Article Text |
id | pubmed-4089283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Avicenna Organ Transplantation Institute |
record_format | MEDLINE/PubMed |
spelling | pubmed-40892832014-07-10 Current Status of Pancreas and Islet Cell Transplantation Saidi, R. F. Int J Organ Transplant Med Review Pancreas transplantation has emerged as an effective treatment for patients with diabetes mellitus, especially those with established end-stage renal disease. Surgical and immunosuppressive advances have significantly improved allograft survival. The procedure reduces mortality compared with diabetic kidney transplant recipients and wait listed patients. Improvements in diabetic nephropathy and retinopathy have also been demonstrated. Pancreas transplantation can improve cardiovascular risk profiles, improve cardiac function and decrease cardiovascular events. Lastly, improvements in diabetic neuropathy and quality of life can result from pancreas transplantation. Pancreas transplantation remains the most effective method to establish durable euglycemia for patients with diabetes mellitus. Avicenna Organ Transplantation Institute 2012 2012-05-01 /pmc/articles/PMC4089283/ /pubmed/25013624 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Saidi, R. F. Current Status of Pancreas and Islet Cell Transplantation |
title | Current Status of Pancreas and Islet Cell Transplantation |
title_full | Current Status of Pancreas and Islet Cell Transplantation |
title_fullStr | Current Status of Pancreas and Islet Cell Transplantation |
title_full_unstemmed | Current Status of Pancreas and Islet Cell Transplantation |
title_short | Current Status of Pancreas and Islet Cell Transplantation |
title_sort | current status of pancreas and islet cell transplantation |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089283/ https://www.ncbi.nlm.nih.gov/pubmed/25013624 |
work_keys_str_mv | AT saidirf currentstatusofpancreasandisletcelltransplantation |